Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 3.25
High: 3.25
Low: 3.25
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS UPDATES: Windward widens loss as operating expenses rise

Wed, 31st Aug 2022 13:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Chesterfield Resources PLC - mineral exploration company with projects in Cyprus and Canada - In the six months ended June 30, reports a widened loss of GBP491,607. The previous year its loss totalled GBP433,538. Posts revenue of GBP45,132, up from nil the prior year. Total assets at June 30 amount to GBP6.5 million, up from GBP6.1 million at December 31. Says it is "comfortable" with its immediate cash position but is mindful of "difficult" capital market conditions. Begins programme to cut ongoing running and board costs by 50%.

----------

ValiRx PLC - life science company focused on clinical stage cancer therapeutic development and women's health - In the six months ended June 30, widens its pretax loss to GBP1.1 million from GBP785,434 the previous year. Research & development costs increase to GBP200,531 from GBP166,500 year-on-year. Company says it has sufficient funding to continue building its development pipeline and to continue exploring options to create a translational contract research organisation, with a view to adding further revenue streams.

----------

Windward Ltd - maritime predictive intelligence firm - In the six months ended June 30, reports a widened loss of USD9.9 million against a loss of USD4.0 million the previous year. Revenue climbs to USD10.9 million from USD8.1 million. Operating expenses, however, surge to USD14.3 million from USD9.8 million a year prior. Annual contract value grows 23% year-on-year to USD22.5 million from USD18.4 million as a result of new customer wins and upselling to existing customers. Notes positive trading has continued into the second half of 2022, with demand for data-driven analysis and solutions across the maritime ecosystem "stronger than ever." Chief Executive Ami Daniel says the firm's outlook remains positive.

----------

Dev Clever Holdings PLC - developer of career guidance, learning and development platforms - In the six months ended April 30, reports a significantly widened pretax loss of GBP3.9 million from a loss of GBP297,053 the previous year. Revenue rises to GBP3.3 million from GBP2.4 million, while cost of sales rises sharply to GBP2.3 million from GBP834,415 the previous year. Company also announces the completion of the purchases of Veative Labs Private Ltd and the residual intellectual property from Veative Pte Ltd Singapore. Adds the merger of the businesses means the group is now singularly focused on growth acceleration. Says focus moving forward is on user acquisition through the roll-out of its lauchmycareer.com platform.

----------

Zenova Group PLC - provider of fire safety and heat management technology and products - In the six months ended May 31, widens its pretax loss to GBP1.0 million from GBP217,000 the previous year. Says the loss was driven by spending on product development, testing, and marketing. Posts revenue of GBP75,000 compared to nil a year prior as a result of international sales contracts. Chief Executive Tony Crawley says the company is well funded and has "rigorous" cost controls in place to manage the expansion of the business.

----------

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment.

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice.

Read more
12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

Read more
12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics.

Read more
9 Feb 2024 20:24

TRADING UPDATES: ValiRx receives shareholder request for board change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Dec 2023 15:56

UK shareholder meetings calendar - next 7 days

Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
Monday 1 January 
no events scheduled 
Tuesday 2 January 
no events scheduled 
Wednesday 3 January 
Jubilee Metals Group PLCGM re equity raise
Thursday 4 January 
Rotala PLCGM re management buyout
Tintra PLCGM re cancellation, re-registering as private company
ValiRx PLCGM re operational review
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
19 Dec 2023 20:46

IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares.

Read more
13 Dec 2023 21:14

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Dec 2023 15:08

ValiRx enters option deal with Ambrose Healthcare

(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.

Read more
5 Dec 2023 11:17

ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose

(Alliance News) - ValiRx PLC on Tuesday said that ValiSeek Ltd it has entered a deal to licence VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.

Read more
5 Dec 2023 10:59

AIM WINNERS & LOSERS: tinyBuild warns on revenue; ValiRx rises

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
10 Nov 2023 11:49

ValiRx signs deal to evaluate StingRay Bio drug candidates

(Alliance News) - ValiRx PLC on Friday said it has signed a deal with StingRay Bio Ltd to investigate a series of drug candidates.

Read more
10 Nov 2023 10:32

ValiRx enters partnership with StingRay Bio

(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.

Read more
6 Oct 2023 11:35

ValiRx sees no reason for shares jump; notes TheoremRx mulls merger

(Alliance News) - ValiRx PLC on Friday said it had no unpublished information that was sensitive to its share price, as it rose significantly.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.